Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07TNE
|
||||
| Former ID |
DIB019942
|
||||
| Drug Name |
GSK126
|
||||
| Synonyms |
GSK 126; GSK-126
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [532074] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C31H38N6O2
|
||||
| InChI |
InChI=1S/C31H38N6O2/c1-6-22(5)37-18-20(3)29-25(30(38)34-17-26-19(2)13-21(4)35-31(26)39)14-24(15-27(29)37)23-7-8-28(33-16-23)36-11-9-32-10-12-36/h7-8,13-16,18,22,32H,6,9-12,17H2,1-5H3,(H,34,38)(H,35,39)/t22-/m0/s1
|
||||
| InChIKey |
FKSFKBQGSFSOSM-QFIPXVFZSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Enhancer of zeste homolog 2 | Target Info | Inhibitor | [532010] | |
| KEGG Pathway | MicroRNAs in cancer | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| WikiPathways | Interactome of polycomb repressive complex 2 (PRC2) | ||||
| Endoderm Differentiation | |||||
| Integrated Pancreatic Cancer Pathway | |||||
| Histone Modifications | |||||
| Cell Differentiation - meta | |||||
| miRs in Muscle Cell Differentiation | |||||
| miR-targeted genes in muscle cell - TarBase | |||||
| miR-targeted genes in lymphocytes - TarBase | |||||
| miR-targeted genes in epithelium - TarBase | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.